# The Medical Applications of Novel PET Radiopharmaceuticals

**Authors:** Jonathan Vigne, Florent L. Besson

PMC · DOI: 10.3390/ph18101512 · Pharmaceuticals · 2025-10-09

## Full-text entities

- **Genes:** FOLH1 (folate hydrolase 1) [NCBI Gene 2346] {aka FGCP, FOLH, GCP2, GCPII, NAALAD1, PSM}
- **Diseases:** cancer (MESH:D009369), head and neck cancers (MESH:D006258), inflammation (MESH:D007249), injury to (MESH:D014947), prostate cancer (MESH:D011471), fibrosis (MESH:D005355), glioma (MESH:D005910), IgG4-related disease (MESH:D000077733), neurological disorders (MESH:D009461), fibrotic disorders (MESH:D009358), infection (MESH:D007239), cardiovascular diseases (MESH:D002318), Crohn's disease (MESH:D003424), neuro-oncological disorders (MESH:D000072716), bladder cancer (MESH:D001749), interstitial lung disease (MESH:D017563)
- **Chemicals:** [18F]FET (MESH:C545932), amino acid (MESH:D000596), [18F]FDG (MESH:D019788), [68Ga]Ga-FAPI (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12566617/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12566617/full.md

---
Source: https://tomesphere.com/paper/PMC12566617